Atogepant (Qulipta®) for migraine prevention

Trends Pharmacol Sci. 2022 Aug;43(8):701-702. doi: 10.1016/j.tips.2022.03.013. Epub 2022 Apr 22.

Authors

Debbie L Hay¹, Christopher S Walker², Paul W R Harris²

Affiliations

¹ Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand. Electronic address: debbie.hay@otago.ac.nz.
² School of Biological Sciences, University of Auckland, Auckland, New Zealand.

PMID: 35469689
DOI: 10.1016/j.tips.2022.03.013

No abstract available

MeSH terms

Analgesics
Calcitonin Gene-Related Peptide
Calcitonin Gene-Related Peptide Receptor Antagonists*
Humans
Migraine Disorders* / drug therapy
Migraine Disorders* / prevention & control
Piperidines
Pyridines
Pyrroles
Spiro Compounds

Substances

Analgesics
Calcitonin Gene-Related Peptide Receptor Antagonists
Piperidines
Pyridines
Pyrroles
Spiro Compounds
atogepant
Calcitonin Gene-Related Peptide